Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: Association with cerebral inflammation

Archives of Neurology

Volumn 55, Issue 1, 1998, Pages 66-72

  Fassbender, Klaus ^a   Schmidt, Roland ^a   Mößner, Reinald ^a   Kischka, Udo ^a   Kühnen, Josy ^a   Schwarte, Andreas ^a   Hennerici, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GADOLINIUM PENTETATE;

ADULT; AFFECTIVE NEUROSIS; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; ENCEPHALITIS; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; MALE; MULTIPLE SCLEROSIS; NEUROENDOCRINE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROVOCATION TEST;

ADULT; ANXIETY; CORTICOTROPIN-RELEASING HORMONE; CROSS-SECTIONAL STUDIES; DEPRESSION; DEXAMETHASONE; ENCEPHALITIS; FEMALE; GADOLINIUM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOOD DISORDERS; MULTIPLE SCLEROSIS; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES;

EID: 0031911483     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.1.66     Document Type: Article

References (42)

1. Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. Br J Psychiatry. 1969;115:749-764.
2. Grant I. Neuropsychological and psychiatric disturbances in multiple sclerosis: In: McDonald WI, Silberberg DH, eds. Multiple Sclerosis. London, England: Butterworth; 1986:134-152.
3. Joffe RT, Lippert GP, Gray TA, Sawa G, Horwath Z. Mood disorder and multiple sclerosis. Arch Neurol. 1987;44:376-378.
4. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis: review and recommendations for clinical research. Arch Neurol. 1990;47:98-104.
5. Sadovnick NO, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology. 1996;46:628-632.
6. Holsboer F, Grasser A, Friess E, Wiedemann K. Steroid effects on central neurons and implications for psychiatric and neurological disorders. Ann N Y Acad Sci. 1994;746:345-359.
7. Reder AT, Lowy MT, Meltzer HY, Antel JP. Dexamethasone suppression test abnormalities in multiple sclerosis in relation to ACTH therapy. Neurology. 1987;37:849-853.
8. Michelson D, Stone L, Galliven E, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab. 1994;79:848-853.
9. Purba JS, Raadsheer FC, Ravid R, Polman CH, Kamphorst W, Swaab DF. Increased number of corticotropin releasing hormone (CRH) neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinology. 1995;62:62-70.
10. Reder AT, Makowiec RL, Lowy MT. Adrenal size is increased in multiple sclerosis. Arch Neurol. 1994;51:151-154.
11. Baldessarini RJ, Arana GW. Does the dexamethasone suppression test have clinical utility in psychiatry? J Clin Psychiatry. 1985;46:25-29.
12. Heuser I, Yassouridis A, Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res. 1994;28:341-356.
13. Grasser A, Möller A, Backmund H, Yassouridis A, Holsboer F. Heterogeneous hypothalamic-pituitary-adrenal-system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp Clin Endocrinol Diabetes. 1996;104:31-37.
14. Hopkins SJ, Rothwell NJ, Dantzer R. How do cytokines say hello to the brain? neural versus humoral mediation. Eur Cytokine Netw. 1994;5:271-273.
15. Arimura A, Takaki A, Komaki G. Interactions between cytokines and the hypothalamic-pituitary-adrenal axis during stress. Ann N Y Acad Sci. 1994;739:270-281.
16. Ader R, Cohen N, Felten D. Psychoneuro-immunology: interactions between the nervous system. Lancet. 1995;345:99-103.
17. Fassbender K, Ries S, Schminke U, Schneider S, Hennerici M. Inflammatory cytokines in CSF in bacterial meningitis: association with altered blood flow velocities in basal cerebral arteries. J Neurol Neurosurg Psychiatry. 1996;61:57-61.
18. Ovadia H, Abramsky O, Barak V, Conforti N, Saphier D, Weidenfeld J. Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferented male rats. Exp Brain Res. 1989;76:246-249.
19. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 1987;238:522-524.
20. Rudick BA, Ransohoff RM. Cytokine secretion by multiple sclerosis monocytes: relation to disease activity. Arch Neurol. 1992;49:265-270.
21. Brosnan CF, Cannella B, Battistini L, Raine CS. Cytokine localization in multiple sclerosis lesions: correlation with adhesion molecule expression and reactive nitrogen species. Neurology. 1995;45(suppl 6):S16-S21.
22. Arnason B. The role of cytokines in multiple sclerosis. Neurology. 1995;45(suppl 6):S54-S55.
23. Tsukada N, Miyagi K, Matsuda M, Yanagisawa N. Increased levels of intercellular adhesion molecule-1 in multiple sclerosis and human T-lymphotropic virus type 1-associated myelopathy. Ann Neurol. 1993;33:646-649.
24. Fassbender K, Schminke U, Ries S, Ragoschke A. Hennerici M. Endothelial-derived adhesion molecules in bacterial meningitis: association to cytokine release and intrathecal leukocyte-recruitment. J Neuroimmunol. 1997;74:130-134.
25. Whitaker JN, Herman PK. Human myelin basic protein peptide 69-89: immunochemical features and use in immunoassays of cerebrospinal fluid. J Neuroimmunol. 1988;19:47-57.
26. McIvor GP, Riklan M, Reznikoff M. Depression in multiple sclerosis as a function of length and severity of illness, age, remission and perceived social support. J Clin Psychol. 1984;40:1028-1033.
27. Foley WF, Traugott U, LaRocca NG, et al. A prospective study of depression and immune dysregulation in multiple sclerosis. Arch Neurol. 1992;49:238-244.
28. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13:227-231.
29. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983;33:1444-1452.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
31. Hamilton M. The assessment of anxiety status by rating. Br J Med Psychol. 1959;32:50-55.
32. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63-70.
33. Zung WWK. A rating instrument for anxiety disorders. Psychosomatics. 1991;12:371-379.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
35. Von Bardeleben U, Holsboer F. Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. Neuroendocrinology. 1989;1:485-488.
36. Paty DW, McFarlin DE, McDonald WI. Magnetic resonance imaging and laboratory aids in the diagnosis of multiple sclerosis. Ann Neurol. 1991;29:3-5.
37. Schiffer RB, Babigian HM. Behavioral disorders in multiple sclerosis, temporal lobe epilepsy, and amyotrophic lateral sclerosis: an epidemiologic study. Arch Neurol. 1984;41:1067-1069.
38. Wells KB, Golding JM, Burnam MA. Psychiatric disorders in a sample of general population with and without chronic medical conditions. Am J Psychiatry. 1988;145:976-981.
39. Matthews KB. Multiple sclerosis presenting with acute remitting psychiatric symptoms. J Neurol Neurosurg Psychiatry. 1979;42:859-863.
40. Sternberg EM, Young WS, Bernadini R, Calogero AE, Chrousos GP, Wilder RL. A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A. 1989;86:4771-4775.
41. MacPhee IAM, Antoni FA, Mason DW. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med. 1989;169:431-435.
42. Mason D, MacPhee I, Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunology. 1990;70:1-5.